TREATMENT WITH ANTI-TNF BIOLOGICS IN PATIENT WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS DOES NOT INCREASE THE RISK OF MALIGNANCY

被引：0
|
作者：
Fanto, M. [1 ]
Peragallo, M. [2 ]
Pietrosanti, M. [1 ]
Sorgi, M. L. [1 ]
Salemi, S. [1 ]
D'Amelio, R. [1 ]
机构：
[1] Univ Roma La Sapienza, Fac Med & Psicol, I-00185 Rome, Italy
[2] Italian Army, Med & Veterianary Res Ctr, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
METAANALYSIS; THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：438 / 438
页数：1
相关论文
共 50 条
  • [1] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [2] Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis
    Lanfant-Weybel, Karine
    Lequerre, Thierry
    Vittecoq, Olivier
    PRESSE MEDICALE, 2009, 38 (05): : 774 - 787
  • [3] METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Deyab, G.
    Hokstad, I.
    Smastuen, M. C.
    Agewall, S.
    Hollan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 704 - 704
  • [4] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
    Haberhauer, Guenther
    Strehblow, Christoph
    Fasching, Peter
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224
  • [5] Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
    Cantini, Fabrizio
    Nannini, Carlotta
    Niccoli, Laura
    Petrone, Linda
    Ippolito, Giuseppe
    Goletti, Delia
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [6] PATIENT ELIGIBILITY AND USE OF BIOLOGICS IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE UNITED STATES
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    VALUE IN HEALTH, 2013, 16 (07) : A572 - A572
  • [7] COST MINIMIZATION OF ANTI-TNF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITIS, AKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2012, 15 (04) : A36 - A36
  • [8] COST-MINIMIZATION ANALYSIS OF ANTI-TNF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Scaccabarozzi, L.
    VALUE IN HEALTH, 2014, 17 (03) : A229 - A229
  • [9] Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
    Bonovas, Stefanos
    Minozzi, Silvia
    Lytras, Theodore
    Gonzalez-Lorenzo, Marien
    Pecoraro, Valentina
    Colombo, Silvia
    Polloni, Ilaria
    Moja, Lorenzo
    Cinquini, Michela
    Marino, Valentina
    Goletti, Delia
    Matucci, Andrea
    Tocci, Giuliano
    Milano, Giuseppe Maria
    Scarpa, Raffaele
    Cantini, Fabrizio
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 : 35 - 54
  • [10] Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
    Minozzi, Silvia
    Bonovas, Stefanos
    Lytras, Theodore
    Pecoraro, Valentina
    Gonzalez-Lorenzo, Marien
    Bastiampillai, Anan Judina
    Gabrielli, Eugenia Maria
    Lonati, Andrea Carlo
    Moja, Lorenzo
    Cinquini, Michela
    Marino, Valentina
    Matucci, Andrea
    Milano, Giuseppe Maria
    Tocci, Giuliano
    Scarpa, Raffaele
    Goletti, Delia
    Cantini, Fabrizio
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 : 11 - 34
12345